Jason Laine

President Trump’s DOJ Sweeps Away Barriers for Medical Marijuana Research 0
- MEDICAL MARIJUANA
- September 16, 2025
In a landmark regulatory shift, President Donald Trump’s Department of Justice has rescinded dozens of pending and projected rules, dismantling longstanding DEA obstacles to medical cannabis research. The decisive move, announced September 15, strips away the procedural shields that allowed the DEA to delay legitimate marijuana science, notably for FDA-authorized clinical trials targeting Huntington’s disease
READ MORE
Trump Weighs Cannabis Reclassification as States Push Ahead 0
- CANNABIS OIL
- September 11, 2025
Donald Trump is considering reclassifying cannabis from a Schedule I drug to Schedule III, a move that would ease federal restrictions but stop short of national legalization. Currently, cannabis sits alongside heroin under Schedule I, defined as having “no accepted medical use.” Yet 40 states permit cannabis for medical purposes, and 24 of those also
READ MORE

Massachusetts Lawmakers Advance Cannabis Employment and Medical Expansion Bills 0
- MEDICAL MARIJUANA
- September 9, 2025
Massachusetts legislators are moving forward with two major cannabis reform measures aimed at expanding patient access and strengthening worker protections. One bill, sponsored by Rep. Michael Soter (R), would add post-traumatic stress disorder (PTSD) and opioid use disorder to the list of qualifying conditions for medical cannabis, while also ensuring military veterans with VA documentation
READ MORE
Many IBD Patients Turn to Cannabis and CBD for Symptom Relief, Study Finds 0
- CANNABIS OIL
- September 4, 2025
A new study highlights that a notable proportion of people living with inflammatory bowel disease (IBD) are turning to cannabis and CBD oil to help manage symptoms such as pain, stress, and anxiety. Researchers at Case Western Reserve University surveyed 139 adults—106 of whom had IBD—and found that nearly two-thirds reported using cannabis or CBD.
READ MORE